Synthesis of cationic β-cyclodextrin derivatives and their applications as chiral stationary phases for high-performance liquid chromatography and supercritical fluid chromatography

被引:60
作者
Wang, Ren-Qi [1 ]
Ong, Teng-Teng [1 ]
Ng, Siu-Choon [1 ]
机构
[1] Nanyang Technol Univ, Coll Engn, Dept Chem & Biomol Engn, Singapore 637722, Singapore
关键词
beta-cyclodextrin derivatives; chiral stationary phases; supercritical fluid chromatography; high-performance liquid chromatography; enantioseparation;
D O I
10.1016/j.chroma.2008.07.046
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Four cationic beta-cycloclextrin derivatives, namely mono-6-(3-methylimidazolium)-6-deoxy-perphenyl-carbamoyl-beta-cyclodextrin chloride (MPCCD), mono-6-(3-methylimidazolium)-6-deoxyper(3,5-dimethylphenylcarbamoyl)-beta-cyclodextrin chloride (MDPCCD), mono-6-(3-octylimidazolium)-6-deoxyperphenylcarbamoyl-beta-cyclodextrin chloride (OPCCD) and mono-6-(3-octylimidazolium)-6-deoxyper(3,5-dimethylphenylcarbamoyl)-beta-cyclodextrin chloride (ODPCCD), have been synthesized and physically coated onto porous spherical silica gel to obtain novel chiral stationary phases (CSPs). The performances of these CSPs are studied on high-performance liquid chromatography (HPLC) and supercritical fluid chromatography (SFC) using 18 racemic aryl alcohols as test analytes. Among these four CSPS, OPCCD shows the best separation results for all analytes on both HPLC and SFC analyses. Chromatographic studies reveal that the CSPs consisting of an n-octyl group on the imidazolium moiety and phenylcarbarnoyl groups On the cyclodextrin ring provide enhancement of analyte-chiral Substrate interactions over CSPs bearing the methyl group on the imidazolium moiety and 3,5-dimethylphenylcarbamoyl groups on the cyclodextrin ring. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 33 条
[11]   High-performance liquid chromatography chiral stationary phases based on low-molecular-mass selectors [J].
Gasparrini, F ;
Misiti, D ;
Villani, C .
JOURNAL OF CHROMATOGRAPHY A, 2001, 906 (1-2) :35-50
[12]   Preparation of a beta-cyclodextrin-modified N-carboxymethylchitosan and its chromatographic behavior as a chiral HPLC stationary phase [J].
Kurauchi, Y ;
Ono, H ;
Wang, B ;
Egashira, N ;
Ohga, K .
ANALYTICAL SCIENCES, 1997, 13 (01) :47-52
[13]   SYSTEMATIC STUDY ON THE RESOLUTION OF DERIVATIZED AMINO-ACIDS ENANTIOMERS ON DIFFERENT CYCLODEXTRIN-BONDED STATIONARY PHASES [J].
LEE, SH ;
BERTHOD, A ;
ARMSTRONG, DW .
JOURNAL OF CHROMATOGRAPHY, 1992, 603 (1-2) :83-93
[14]   Validation of direct assay of an aqueous formulation of a drug compound AZY by chiral supercritical fluid chromatography (SFC) [J].
Mukherjee, Partha S. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (02) :464-470
[15]   A comparison of ionic liquids to molecular organic solvents as additives for chiral separations in micellar electrokinetic chromatography [J].
Mwongela, Simon M. ;
Siminialayi, Noreen ;
Fletcher, Kristin A. ;
Warner, Isiah M. .
JOURNAL OF SEPARATION SCIENCE, 2007, 30 (09) :1334-1342
[16]   PREPARATION AND CHROMATOGRAPHIC CHARACTERISTICS OF A CHIRAL-RECOGNIZING PERPHENYLATED CYCLODEXTRIN COLUMN [J].
NAKAMURA, K ;
FUJIMA, H ;
KITAGAWA, H ;
WADA, H ;
MAKINO, K .
JOURNAL OF CHROMATOGRAPHY A, 1995, 694 (01) :111-118
[17]   Effect of charged and uncharged chiral additives on the resolution of amlodipine enantiomers in liquid chromatography and capillary electrophoresis [J].
Owens, PK ;
Fell, AF ;
Coleman, MW ;
Berridge, JC .
JOURNAL OF CHROMATOGRAPHY A, 1998, 797 (1-2) :187-195
[18]   CONSIDERATIONS OF CHIRAL RECOGNITION RELEVANT TO THE LIQUID-CHROMATOGRAPHIC SEPARATION OF ENANTIOMERS [J].
PIRKLE, WH ;
POCHAPSKY, TC .
CHEMICAL REVIEWS, 1989, 89 (02) :347-362
[19]   Enantiomeric resolution of doxazosin mesylate and its process-related substances on polysaccharide chiral stationary phases [J].
Rao, RN ;
Nagaraju, D ;
Raju, AN .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (03) :766-773
[20]   STEREOISOMERS AND DRUG TOXICITY - THE VALUE OF SINGLE STEREOISOMER THERAPY [J].
SCOTT, AK .
DRUG SAFETY, 1993, 8 (02) :149-159